We render hundreds of opinions a year ranging from a single opinion on a specific patent to providing long-term, ongoing counseling on complex patent portfolios or litigation. We routinely address patent validity, enforceability, freedom to operate (FTO), misuse, design-around issues, licensing potential, IP contract construction and enforcement, and export controls. We regularly partner with our clients’ legal, business, and technical staffs to identify the potential for risk and reward, from idea to revenue-generating portfolios.
In addition to transactional counseling, we routinely advise clients on prelitigation strategies. Our extensive litigation experience gives us firsthand insight into the various types of arguments opponents may raise. Combining our litigation and IP transactional experience allows us to help guide our clients to favorable settlements of disputes before or during litigation.
Filed an amicus brief on behalf of non-parties Toyota Motor Corporation, Honda Motor Company, Nissan Motor Company, DENSO Corporation, and Hyundai Motor Company in a Federal Circuit appeal involving issues related to standard-essential patents.
18-1363, -1380, -1382, -1732, Fed. Cir., Judges Newman, Chen, Hughes
Finnegan prepared and prosecuted patents for startup Hutchison Medipharma in the United States for the treatment of metastatic colorectal cancer. Those patents cover a small molecule, fruquintinib, which received approval in China.
Finnegan successfully generated patents to cover protease inhibitor Viracept®, for then startup company Agouron Pharmaceuticals, Inc. Agouron was ultimately acquired by Warner-Lambert (now part of Pfizer) based on the strength of the Viracept® patents, for $2.1 billion.
Webinar
January 11, 2024
Webinar
Seminar
September 5, 2023
Tel Aviv
IP Updates
Senate Legislation Proposes Changes to Patent Eligibility and PTAB Proceedings
June 27, 2023
Webinar
June 16, 2022
Webinar
Commentary
How I Made Partner: Finnegan's Danielle Duszczyszyn Shares Six Keys to Business Development Success
December 16, 2020
Press Release
Esther H. Lim Nominated as Candidate for President-Elect of the D.C. Bar
March 6, 2017
Due to international data regulations, we’ve updated our privacy policy. Click here to read our privacy policy in full.
We use cookies on this website to provide you with the best user experience. By accepting cookies, you agree to our use of cookies. Please note that if you opt not to accept or if you disable cookies, the “Your Finnegan” feature on this website will be disabled as well. For more information on how we use cookies, please see our Privacy Policy.
Finnegan is thrilled to announce the launch of our new blog, Ad Law Buzz, devoted solely to breaking news, developments, trends, and analysis in advertising law.